ACBT With Incentive Spirometry Versus High-Frequency Chest Wall Oscillation After Thoracic Surgery
Effects of Active Cycle of Breathing Techniques With Incentive Spirometry Versus High-Frequency Chest Wall Oscillation on Cough, Sputum, Pulmonary Function Test and Patient Satisfaction After Thoracic Surgery
研究概览
地位
条件
详细说明
Postoperative pulmonary complications are common after thoracic surgery due to reduced lung function and impaired secretion clearance. Effective respiratory physiotherapy is essential to improve recovery and prevent complications such as atelectasis and pneumonia.
This randomized clinical trial aims to compare the effectiveness of Active Cycle of Breathing Techniques combined with Incentive Spirometry (ACBT + IS) and High-Frequency Chest Wall Oscillation (HFCWO) in improving respiratory outcomes. A total of 42 patients undergoing elective thoracic surgery will be randomly assigned to either ACBT + IS or HFCWO, along with standard postoperative care.
Outcomes including cough effectiveness, sputum clearance, pulmonary function (FEV₁, FVC), and patient satisfaction will be assessed at baseline, postoperative day 3, and day 5. The study seeks to identify the more effective airway clearance technique to enhance recovery and reduce postoperative complications.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Muhammad Iqbal Tariq, Phd*
- 电话号码:03338236752
- 邮箱:iqbal.tariq@riphah.edu.pk
学习地点
-
-
Punjab Province
-
Lahore、Punjab Province、巴基斯坦、40100
- Gulab Devi Hospital or General Hospital Lahore.
-
接触:
- Arjumand Bano, MS-CPPT
- 电话号码:03059551883
- 邮箱:arjumand.bano@riphah.edu.pk
-
首席研究员:
- Sarah Nasir, MS-CPPT
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Adults aged 18-40 years
- Patients scheduled for elective thoracic surgery (e.g., lobectomy, pneumonectomy, thoracotomy, or VATS)
- Hemodynamically stable in the postoperative period
- Cognitively and physically able to perform breathing exercises and use devices (incentive spirometer/HFCWO vest)
- Willing to participate and provide informed consent
Exclusion Criteria:
- Pre-existing severe pulmonary diseases (e.g., COPD, cystic fibrosis, bronchiectasis)
- Contraindications to HFCWO (e.g., recent rib fractures, chest wall trauma, unstable cardiovascular status)
- Cognitive, neuromuscular, or musculoskeletal impairments limiting participation in interventions
- Prolonged mechanical ventilation (>24 hours postoperatively)
- Active pulmonary infection or hemoptysis within one week after surgery
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:ACBT with Incentive Spirometry
Participants in this group will receive Active Cycle of Breathing Techniques (ACBT) combined with Incentive Spirometry along with standard postoperative care.
The ACBT protocol will include breathing control, thoracic expansion exercises, and forced expiratory techniques (huffing), performed multiple times daily.
Incentive spirometry will be used to promote deep breathing and lung expansion.
The intervention will begin in the early postoperative period and continue for 5 days.
|
A structured breathing intervention combining Active Cycle of Breathing Techniques (breathing control, thoracic expansion exercises, and forced expiratory technique) with incentive spirometry to promote lung expansion and secretion clearance.
Performed multiple times daily during the early postoperative period.
其他名称:
|
|
实验性的:High-Frequency Chest Wall Oscillation (HFCWO)
Participants in this group will receive High-Frequency Chest Wall Oscillation therapy using an oscillatory vest device along with standard postoperative care.
The device delivers external chest wall oscillations to mobilize pulmonary secretions.
The intervention will start on postoperative day 3 and will be administered twice daily for 5 days.
|
A mechanical airway clearance technique delivered using an oscillatory vest that produces high-frequency chest wall vibrations to help mobilize and remove pulmonary secretions.
The intervention is administered twice daily beginning on postoperative day 3.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Forced Expiratory Volume in 1 second (FEV₁)
大体时间:Baseline (preoperative), Postoperative Day 3, and Day 5
|
Assessment of pulmonary function using spirometry parameters including Forced Expiratory Volume in 1 second (FEV₁) to evaluate respiratory recovery after thoracic surgery.
|
Baseline (preoperative), Postoperative Day 3, and Day 5
|
|
Forced Vital Capacity (FVC)
大体时间:Baseline (preoperative), Postoperative Day 3, and Day 5
|
Assessment of pulmonary function using spirometry parameters including Forced Vital Capacity (FVC) to evaluate respiratory recovery after thoracic surgery.
|
Baseline (preoperative), Postoperative Day 3, and Day 5
|
|
Cough Effectiveness
大体时间:Baseline, Postoperative Day 3, and Day 5
|
Evaluation of cough effectiveness using the Leicester Cough Questionnaire (LCQ), measuring physical, psychological, and social impact of cough.
|
Baseline, Postoperative Day 3, and Day 5
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Sputum Clearance
大体时间:Postoperative Day 3 and Day 5
|
Measurement of sputum volume to assess effectiveness of airway clearance techniques.
|
Postoperative Day 3 and Day 5
|
合作者和调查者
调查人员
- 首席研究员:Arjumand Bano, MSPT、Riphah International University
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.